top of page

Example predictive testing template for reporting a positive CHEK2 or ATM germline pathogenic/likely pathogenic variant

Current Version: v1.1 Jan 2024 (Updated: Minor wording change to clarify for 'Implications' and 'Result' sections)

Previous version: v1.0 May 2022

Example predictive testing template for reporting a positive CHEK2 or ATM germline pathogenic/likely pathogenic variant

Current Version: v1.0 May 2022

Example predictive testing template for reporting a BRCA or PALB2 germline pathogenic/likely pathogenic variant (reduced penetrance)

Current Version: v1.1 Jan 2024 (Updated: Minor wording change to clarify for 'Implications' and 'Result' sections, added 'Reduced Penetrance' to summary box). 

Previous version: v1.0 May 2022

Example predictive testing template for reporting a positive BRCA1 or PALB2 germline pathogenic/likely pathogenic variant

Current Version: v1.1 May 2022

Previous version: v1.0 June 2021

Example predictive testing template for reporting a positive BRCA2 germline pathogenic/likely pathogenic variant

Current Version: v1.1 May 2022

Previous version: v1.0 June 2021

Example predictive testing template for reporting a positive BRCA or PALB2 germline pathogenic/likely pathogenic variant

Current Version: v1.2 Jan 2024 (Updated: Minor wording change to clarify 'Implications' section)

Previous version: v1.1 May 2022; (BRCA only) v1.0 June 2021

Example predictive testing template for reporting a positive BRCA or PALB2 germline pathogenic/likely pathogenic variant (reduced penetrance)

Current Version: v1.1 Jan 2024 (Updated: Minor wording change to clarify 'Implications' section, added 'reduced penetrance' to summary section)

Previous version: v1.0 May 2022

Example predictive testing template for reporting a negative variant for the R208 germline panel

Current Version: v1.1 May 2022

Previous version: v1.0 June 2021

PREDICTIVE: Report Templates

External Resources

ACGS

The Association for Clinical Genomic Science brings together scientists working within genetics into one professional association.

JMG Paper

Cancer Variant Interpretation Group UK (CanVIG-UK): an exemplar national subspecialty multidisciplinary network.

 

Journal of Medical Genetics

Published: 13 March 2020.

UKCGG

The UK Cancer Genetics Group.

A multidisciplinary organisation for UK clinicians, counsellors & scientists interested in cancer susceptibility genetics.

ACMG

The American College of Medical Genetics variant interpretation framework can be found on their website. 

bottom of page